Cargando…
Effects of L-dopa on expression of prolactin and synaptotagmin IV in 17β-estradiol-induced prolactinomas of ovariectomized hemiparkinsonian rats
Parkinson’s disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. Dopamine precursor levodopa (L-dopa) is used as the first-line treatment for PD. Evidence suggests neuroprotective effects of estrogens in PD. Since both 17b-estradiol (E...
Autores principales: | Zorović, Maja, Kolmančič, Kaja, Živin, Marko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554698/ https://www.ncbi.nlm.nih.gov/pubmed/33823126 http://dx.doi.org/10.17305/bjbms.2021.5491 |
Ejemplares similares
-
Modulation by Estradiol of L-Dopa-Induced Dyskinesia in a Rat Model of Post-Menopausal Hemiparkinsonism
por: Kolmančič, Kaja, et al.
Publicado: (2022) -
Up-regulation of Synaptotagmin IV within amyloid plaque-associated dystrophic neurons in Tg2576 mouse model of Alzheimer’s disease
por: Tratnjek, Larisa, et al.
Publicado: (2013) -
Association of prolactin receptor (PRLR) variants with prolactinomas
por: Gorvin, Caroline M, et al.
Publicado: (2019) -
Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum
por: Du, Huan, et al.
Publicado: (2015) -
Effects of 17β-estradiol on leptin signaling in anterior pituitary of
ovariectomized rats
por: Yin, Chunhua, et al.
Publicado: (2016)